Synergistic interactions between dmag and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abi+ leukemia cells sensitive and resistant to imatinib mesylate

Synergistic interactions between dmag and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abi+ leukemia cells sensitive and resistant to imatinib mesylate

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cancer research 2006, Vol.12 (7), p.2239-2247
Hauptverfasser: NGUYEN, Tri K, RAHMANI, Mohamed, NING GAO, KRAMER, Lora, CORBIN, Amie S, DRUKER, Brian J, DENT, Paul, GRANTS, Steven
Format: Artikel
Sprache:eng
Schlagworte:
Antineoplastic agents
Biological and medical sciences
Hematologic and hematopoietic diseases
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
Pharmacology. Drug treatments
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2247
container_issue 7
container_start_page 2239
container_title Clinical cancer research
container_volume 12
creator NGUYEN, Tri K
RAHMANI, Mohamed
NING GAO
KRAMER, Lora
CORBIN, Amie S
DRUKER, Brian J
DENT, Paul
GRANTS, Steven
description
format Article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_17697492</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17697492</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_176974923</originalsourceid><addsrcrecordid>eNqNjstOxDAMRSsEEsPjH7xhhapJ-pgyWxCIPexHbuopZhK3igOof8RnEhDsWd27OPfYR8XKtm1X1tWmPc7ddDelaerqtDhTfTXGNtY0q-LzaRGKI2tiByyJIrrEkyj0lD6IBIaAI6AMEDhNI0n5DbxjogHmOCVigQMLKv2FXVfZ9MJ95qPmCrcurrHna_D0dqDACI68V1AS5SyjH38kzW-gJEgTcMDEwj0E0sXnaxfFyR690uVvnhdXD_fPd4_ljOrQ7yOKY93NMS_jsrPdZts126r-L_cFpJVjog</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synergistic interactions between dmag and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abi+ leukemia cells sensitive and resistant to imatinib mesylate</title><source>American Association for Cancer Research</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>NGUYEN, Tri K ; RAHMANI, Mohamed ; NING GAO ; KRAMER, Lora ; CORBIN, Amie S ; DRUKER, Brian J ; DENT, Paul ; GRANTS, Steven</creator><creatorcontrib>NGUYEN, Tri K ; RAHMANI, Mohamed ; NING GAO ; KRAMER, Lora ; CORBIN, Amie S ; DRUKER, Brian J ; DENT, Paul ; GRANTS, Steven</creatorcontrib><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Hematologic and hematopoietic diseases ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>Clinical cancer research, 2006, Vol.12 (7), p.2239-2247</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17697492$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>NGUYEN, Tri K</creatorcontrib><creatorcontrib>RAHMANI, Mohamed</creatorcontrib><creatorcontrib>NING GAO</creatorcontrib><creatorcontrib>KRAMER, Lora</creatorcontrib><creatorcontrib>CORBIN, Amie S</creatorcontrib><creatorcontrib>DRUKER, Brian J</creatorcontrib><creatorcontrib>DENT, Paul</creatorcontrib><creatorcontrib>GRANTS, Steven</creatorcontrib><title>Synergistic interactions between dmag and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abi+ leukemia cells sensitive and resistant to imatinib mesylate</title><title>Clinical cancer research</title><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNjstOxDAMRSsEEsPjH7xhhapJ-pgyWxCIPexHbuopZhK3igOof8RnEhDsWd27OPfYR8XKtm1X1tWmPc7ddDelaerqtDhTfTXGNtY0q-LzaRGKI2tiByyJIrrEkyj0lD6IBIaAI6AMEDhNI0n5DbxjogHmOCVigQMLKv2FXVfZ9MJ95qPmCrcurrHna_D0dqDACI68V1AS5SyjH38kzW-gJEgTcMDEwj0E0sXnaxfFyR690uVvnhdXD_fPd4_ljOrQ7yOKY93NMS_jsrPdZts126r-L_cFpJVjog</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>NGUYEN, Tri K</creator><creator>RAHMANI, Mohamed</creator><creator>NING GAO</creator><creator>KRAMER, Lora</creator><creator>CORBIN, Amie S</creator><creator>DRUKER, Brian J</creator><creator>DENT, Paul</creator><creator>GRANTS, Steven</creator><general>American Association for Cancer Research</general><scope>IQODW</scope></search><sort><creationdate>2006</creationdate><title>Synergistic interactions between dmag and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abi+ leukemia cells sensitive and resistant to imatinib mesylate</title><author>NGUYEN, Tri K ; RAHMANI, Mohamed ; NING GAO ; KRAMER, Lora ; CORBIN, Amie S ; DRUKER, Brian J ; DENT, Paul ; GRANTS, Steven</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_176974923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NGUYEN, Tri K</creatorcontrib><creatorcontrib>RAHMANI, Mohamed</creatorcontrib><creatorcontrib>NING GAO</creatorcontrib><creatorcontrib>KRAMER, Lora</creatorcontrib><creatorcontrib>CORBIN, Amie S</creatorcontrib><creatorcontrib>DRUKER, Brian J</creatorcontrib><creatorcontrib>DENT, Paul</creatorcontrib><creatorcontrib>GRANTS, Steven</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NGUYEN, Tri K</au><au>RAHMANI, Mohamed</au><au>NING GAO</au><au>KRAMER, Lora</au><au>CORBIN, Amie S</au><au>DRUKER, Brian J</au><au>DENT, Paul</au><au>GRANTS, Steven</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synergistic interactions between dmag and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abi+ leukemia cells sensitive and resistant to imatinib mesylate</atitle><jtitle>Clinical cancer research</jtitle><date>2006</date><risdate>2006</risdate><volume>12</volume><issue>7</issue><spage>2239</spage><epage>2247</epage><pages>2239-2247</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub></addata></record>
fulltext fulltext
identifier ISSN: 1078-0432
ispartof Clinical cancer research, 2006, Vol.12 (7), p.2239-2247
issn 1078-0432
1557-3265
language eng
recordid cdi_pascalfrancis_primary_17697492
source American Association for Cancer Research; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Antineoplastic agents
Biological and medical sciences
Hematologic and hematopoietic diseases
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
Pharmacology. Drug treatments
title Synergistic interactions between dmag and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abi+ leukemia cells sensitive and resistant to imatinib mesylate
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T01%3A55%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synergistic%20interactions%20between%20dmag%20and%20mitogen-activated%20protein%20kinase%20kinase%201/2%20inhibitors%20in%20Bcr/abi+%20leukemia%20cells%20sensitive%20and%20resistant%20to%20imatinib%20mesylate&rft.jtitle=Clinical%20cancer%20research&rft.au=NGUYEN,%20Tri%20K&rft.date=2006&rft.volume=12&rft.issue=7&rft.spage=2239&rft.epage=2247&rft.pages=2239-2247&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E17697492%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true